Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by tuesdaynightridon Jun 15, 2015 3:10pm
113 Views
Post# 23832369

RE:RE:Transparency

RE:RE:TransparencyThanks bencro for your opinion
... and I promise that I'll give your post all of the consideration it deserves.

This board just got done discussing the weekend Korelin interview with our star, Roger.
... So let's see, I seem to recall another Korelin report last July 2014 with Roger.
Here are some highlights:

- TLC2000 out to his key field personnel for feedback late Sept 2014
- TLC2000 HC approval expected in October with full sales underway thru most of 4th q 2014
 - TLC2000 approval in US expected early 2015
- FDA/HC ph1/2 start early 2015 with 30 patients 
(actually if you go to April 2014 interviews, Ole Rog was saying trial start in 4th q, 2014)
- Fast track approval possible in 2nd half 2015

Now that's what I call a used car salesman.

... but my apologies, I'm only dealing in facts given in his interview with AL.
By the way bencro, do you remember listening to that interview?
We'll let me answer that one for you... You did listen to it!

Bencro- you need to stop being Roger's Pom Pom girl and start becoming an objective shareholder.
Bullboard Posts